News From the American Society of Hematology (ASH) 2017 Annual Meeting

Patient Power was on-site at the 2017 American Society of Hematology (ASH) meeting in Atlanta to bring you the latest blood cancer-related treatment and research news.

Email this program

Get Link

CLL

Innovative Treatment Strategies for CLL: How Can Patients Become MRD Negative?

Is MRD negative status the treatment goal for CLL? How can patients with unique conditions reach it? CLL expert Dr. Nicole Lamanna discusses different approaches to therapy with novel agents.

Published:

Genetic Testing: What Version of CLL Do I Have and How Do I Treat It?

What do doctors look for in genetic tests for CLL patients? How do the results affect the course of treatment? Find out now from CLL expert Dr. Jennifer Brown.

Published:

Post-FCR: Will Novel Treatments Still Work for My CLL?

CLL experts Dr. Jennifer Brown and Dr. William Wierda joined us at ASH 2017 to discuss the effectiveness of novel agents after an FCR treatment regimen. Watch now to find out more.

Published:

BTK Inhibitor Update From ASH 2017: What Are the Real-World Results?

How effective are BTK inhibitors? Do patients tolerate them well in the real world? Dr. Antony Mato and Dr. Jennifer Brown discuss the latest news on the use of BTK inhibitors for CLL patients at ASH 2017.

Published:

CLL Combination Therapy News From ASH 2017

What new combination therapies for CLL were presented at ASH 2017? Tune in to learn the latest with CLL expert Dr. Michael Choi.

Published:

ASH 2017 Roundtable: CLL Research News and Updates From an Expert Panel

Andrew Schorr hosts an expert roundtable to discuss CLL news from the 2017 American Society of Hematology (ASH) meeting in Atlanta.

Published:

ASH 2017 Daily Wrap: Day Three

In day three of Patient Power’s daily wrap-up from the 2017 ASH meeting in Atlanta, Andrew and Esther Schorr are joined by a panel of experts.

Published:

CML

CML Update From News at ASH 2017

Distinguished CML expert Dr. Michael Mauro joins Patient Power to share the new developments in CML treatment released at the 2017 ASH meeting.

Published:

CAR T-Cell Therapy Update From ASH 2017

Which CAR T-cell treatments are currently approved for cancer treatment? Watch now to hear an update from ASH 2017 with Dr. David Maloney.

Published:

CAR T-Cell Therapy News From ASH 2017

What news on CAR-T cell therapy was released at ASH 2017? Tune in to find out the latest.

Published:

Lymphoma

Lymphoma Treatment News From ASH 2017

Brazilian hematologist Dr. Guilherme Perini reviews the latest lymphoma treatments announced at ASH 2017 and their response from patients.

Published:

Lymphoma Research and Treatment Update From ASH 2017

Dr. Andrew Evens gives us an update from ASH 2017 about new treatments for both Hodgkin and non-Hodgkin lymphoma. Watch to learn the latest from ASH 2017.

Published:

CAR T-Cell Therapy Update From ASH 2017

Which CAR T-cell treatments are currently approved for cancer treatment? Watch now to hear an update from ASH 2017 with Dr. David Maloney.

Published:

The Latest in Mantle Cell Lymphoma From ASH 2017

What new treatment developments for mantle cell lymphoma have been made in 2017? Tune in to hear from Dr. Peter Martin of Weill Cornell Medicine.

Published:

CAR T-Cell Therapy News From ASH 2017

What news on CAR-T cell therapy was released at ASH 2017? Tune in to find out the latest.

Published:

MPNs

Diagnosis and Prognosis: What Mutations Reveal About MPNs

What do driver mutations reveal about your condition’s behavior? Dr. Rami Komrokji and Dr. Mark Heaney joined us at ASH 2017 to discuss the prognostic value and associated therapies for genetic abnormalities in MPNs.

Published:

Predicting Progression in ET and PV: Updates From ASH 2017

What were the updates on ET and PV at ASH 2017? Our panel of MPN experts discuss the latest news on identifying unique mutations, prognostic scoring, and choosing a compatible treatment plan.

Published:

The Latest MPN News: What the Experts Learned at ASH 2017

As part of our ASH 2017 coverage, Dr. John Crispino and Dr. Angela Fleischman, joined Patient Power to share what they learned at this year’s annual meeting. Watch to learn the latest about MPNs.

Published:

ASH 2017 Coverage: An Interferon Update From an MPN Expert

MPN expert and researcher, Dr. Srdan Verstovsek provides an update from ASH 2017, including the two-year results of a European study of interferon for polycythemia vera (PV) treatment.

Published:

MPN News From ASH 2017: Headlines and Updates From an Expert Panel

MPN experts Dr. Mark Heaney, Dr. Rami Komrokji, Dr. Ruben Mesa, Dr. Jamile Shammo and Andrew Schorr discuss the latest news and developments related to research and treatment of MPNs from ASH 2017.

Published:

ASH 2017 Daily Wrap: Day One

Patient Power founders Andrew and Esther Schorr are joined by MPN expert Dr. Naveen Pemmaraju, as they discuss research news from the 2017 ASH meeting.

Published:

Myeloma


How Are Monoclonal Antibodies Being Used in Real-World Clinics?

After a few years of using monoclonal antibodies in clinics, how are myeloma experts implementing them into treatment plans? How have patients responded? Tune in to find out.

Published:

What Is the State of Precision Medicine for Myeloma?

What precision medicine targets are doctors testing for today in myeloma patients? Experts, Dr. Mike Thompson and Dr. Mohit Trikha, joined us at ASH 2017 to discuss.

Published:

Is Some of the Exclusion Criteria in Clinical Trials Causing Roadblocks?

How does exclusion criteria hinder clinical trial participation? Watch as our panel of myeloma experts from ASH 2017 share active efforts to promote patient participation and how you can get involved.

Published:

ASH 2017 Myeloma Update With Patient Advocate Jack Aiello

Long-time patient advocate and multiple myeloma survivor Jack Aiello gives us an update from ASH 2017. Watch to hear the latest about myeloma treatment.

Published:

ASH 2017: New Drugs and Numerous Drug Combinations in Myeloma

With the recent breakthroughs in myeloma therapy from ASH 2017, what should patients be talking to their doctor about? Tune in to find out from Dr. Guilherme Perini.

Published:

CAR T-Cell Therapy Update From ASH 2017

Which CAR T-cell treatments are currently approved for cancer treatment? Watch now to hear an update from ASH 2017 with Dr. David Maloney.

Published:

ASH 2017: Are Experts Personalizing Therapy to the Genetics of a Patient’s Myeloma?

At ASH 2017, Esther Schorr and Dr. Gareth Morgan discuss new oncogenes in myeloma as well as personalizing the therapy to the genetics of the disease.

Published:

CAR T-Cell Therapy News From ASH 2017

What news on CAR-T cell therapy was released at ASH 2017? Tune in to find out the latest.

Published:

ASH 2017 Myeloma Roundtable: Game-Changing Treatment Tools in Myeloma

A roundtable of esteemed myeloma experts including Dr. Carol Ann Huff, Dr. Sagar Lonial and Dr. Suzanne Lentzsch weigh in on the breaking news out of ASH 2017 for myeloma patients.

Published:

ASH 2017 Daily Wrap: Day Two

In day two of Patient Power’s daily wrap-up from ASH 2017, Andrew and Esther Schorr are joined by Dr. Mike Thompson, Dr. Mohit Trikha and patient advocate Cynthia Chmielewski.

Published:

Advertisement
Join Our Community Register For Events Read Our Latest Blog
Advertisement

Page last updated on April 12, 2018